Top3 Homologues in Lymphocyte Genome Stability and Aging
Top3 Homologues in Lymphocyte Genome Stability and Aging
批准号:
7640925
负责人:
Albert C Shaw
金额:
$26.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2011-06-30
关键词:
AddressAgeAgingAllelesAneuploidyAttenuatedAutoantibodiesB-LymphocytesBiological ModelsBloom SyndromeCell Cycle CheckpointCellsCellularityDNADNA DamageDNA RepairDNA StructureDNA TopoisomerasesDataDevelopmentEmbryoEmployee StrikesEnzymesEventFamilyGenesGeneticGenetic RecombinationGenetic TranscriptionGenome StabilityGenomic InstabilityGerm CellsHereditary DiseaseHomologous GeneHuman GeneticsImmune systemImmunoglobulinsImpairmentIsoenzymesLinkLongevityLymphatic DiseasesLymphocyteLymphopoiesisMaintenanceMammalsMediatingMusMutationOrthologous GenePhenotypePlayPremature aging syndromePrincipal InvestigatorProcessProductionProteinsQiRadiation ToleranceRegulationRoleRothmund-Thomson syndromeSiteSplenomegalyStructureT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTOP3A geneTestingTopoisomeraseTransgenic OrganismsV(D)J RecombinationYeastsage relatedhelicasemembermouse modelprogramspromoterrecombinaseresearch studyresponsetopoisomerase IIIalpha
中文摘要
描述(由申请人提供):有大量证据表明,哺乳动物的衰老、基因组稳定性、免疫系统的发育和功能是错综复杂的联系。最近一个引人注目的例子是IA型DNA拓扑异构酶top3 β的失活,导致寿命缩短,体细胞和生殖细胞非整倍体,电离和UV-B辐射敏感性,以及年龄相关性脾肿大和自身抗体产生。DNA拓扑异构酶进行DNA链的顺序断裂和重新连接,以解决DNA链在重组、转录和复制过程中分离的固有结构。对酵母的研究表明,哺乳动物同工酶Top3 α和Top3 β的同源物Top3对基因组稳定至关重要,并与RecQ解旋酶家族成员Sgs1相互作用。值得注意的是,RecQ解旋酶的突变与以早衰和/或基因组不稳定为特征的人类遗传疾病有关,包括Werner和Bloom综合征。我们将使用携带失活的top3 α或top3 β等位基因的小鼠模型来验证IA型拓扑异构酶缺乏导致的基因组不稳定性有助于与衰老相关的表型发展的假设。我们将确定top3 β在维持基因组稳定性和对DNA损伤的反应中的功能。在这方面,与野生型对照相比,缺乏top3 β的小鼠在更年轻的时候出现了与年龄相关的淋巴细胞发育改变;我们将评估由top3 β缺乏引起的基因组不稳定性对淋巴细胞前体与V(D)J重组扩增的潜在影响,并将确定top3 β缺乏的B细胞和T细胞的发育受损是由细胞自主还是非自主机制引起的。最后,由于种系top3 α的失活会导致胚胎死亡,我们将进行淋巴细胞特异性和诱导性的top3 α失活,从而促进对IA型拓扑异构酶功能的明确评估。
英文摘要
DESCRIPTION (provided by applicant): There is substantial evidence that in mammals aging, genomic stability, and development and function in the immune system are intricately linked. A striking recent example is the inactivation of the type IA DNA topoisomerase Top3beta, which results in shortened lifespan, aneuploidy in somatic and germ cells, ionizing and UV-B radiation sensitivity, and age-related splenomegaly and autoantibody production. DNA topoisomerases carry out the sequential breakage and rejoining of DNA strands to resolve structures inherent in the requirement for DNA strands to separate during recombination, transcription and replication. Studies in yeast indicate that Top3, a homologue of the mammalian isozymes Top3alpha and Top3beta, is crucial for genome stability and functionally interacts with Sgs1, a member of the RecQ helicase family. Notably, mutations in RecQ helicases have been linked to human genetic disorders characterized by premature aging and/or genomic instability, including Werner and Bloom syndromes. We will employ mouse models carrying inactivated Top3alpha or Top3beta alleles to test the hypothesis that genomic instability from type IA topoisomerase deficiency contributes to the development of phenotypes associated with aging. We will determine the function of Top3beta in the maintenance of genomic stability and response to DNA damage. In this regard, Top3beta-deficient mice develop age-associated alterations in lymphocyte development at younger ages than wild-type controls; we will assess the potential impact of genomic instability induced by Top3beta deficiency on expansion of lymphocyte precursors vs. V(D)J recombination, and will determine whether impaired development of Top3beta-deficient B and T cells results from cell autonomous or non-autonomous mechanisms. Finally, since germline inactivation of Top3alpha resulted in embryonic lethality, we will carry out lymphocyte-specific and inducible inactivation of Top3alpha, thereby facilitating a definitive assessment of type IA topoisomerase function.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Core D: Clinical Recruitment
-
批准号:10317019
-
项目类别:
-
资助金额:$64.28万
-
财政年份:2020
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:10161669
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:9759735
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:8515284
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:8699112
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:10436887
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:8354266
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Immune responses defining efficiency of influenza vaccination
-
批准号:8307054
-
项目类别:
-
资助金额:$43.19万
-
财政年份:2011
-
负责人:Albert C Shaw
-
依托单位:
Systems investigation of vaccine responses in aging and frailty
-
批准号:10617768
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Core D: Clinical Recruitment
-
批准号:10079823
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Systems investigation of vaccine responses in aging and frailty
-
批准号:10420327
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Clinical subjects and recruitment
-
批准号:10617753
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Clinical subjects and recruitment
-
批准号:10420324
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures
-
批准号:10079825
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7459678
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7097273
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7261905
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:6969008
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Core 003 - Pilot Exploratory Studies Core
-
批准号:10728898
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2002
-
负责人:Albert C Shaw
-
依托单位:
Pilot and Exploratory Studies Core
-
批准号:10202428
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2002
-
负责人:Albert C Shaw
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: